SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-195985
Filing Date
2012-04-30
Accepted
2012-04-30 16:10:02
Documents
6
Period of Report
2012-05-30
Effectiveness Date
2012-04-30

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT d318035ddef14a.htm DEF 14A 1173584
2 GRAPHIC g318035g25b38.jpg GRAPHIC 8622
3 GRAPHIC g318035g41k63.jpg GRAPHIC 7790
4 GRAPHIC g318035g45x09.jpg GRAPHIC 12263
5 GRAPHIC g318035pc1.jpg GRAPHIC 11361
6 GRAPHIC g318035pc2.jpg GRAPHIC 11509
  Complete submission text file 0001193125-12-195985.txt   1246593
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 12795108
SIC: 2834 Pharmaceutical Preparations